**Core Concept**
The question pertains to the neurochemical pathology of Alzheimer's disease, focusing on the deficiency of a specific neurotransmitter in the cortex. Alzheimer's disease is characterized by cognitive decline and is associated with various neurochemical alterations. The **cholinergic hypothesis** is one of the key theories explaining the cognitive deficits in Alzheimer's.

**Why the Correct Answer is Right**
Although the specific correct answer option is missing, based on the context, it is known that in Alzheimer's disease, there is a significant deficiency of **acetylcholine** in the cortex. This deficiency is due to the degeneration of cholinergic neurons in the basal forebrain, which project to the cerebral cortex and are crucial for cognitive functions. The reduction in acetylcholine levels impairs cholinergic neurotransmission, contributing to the cognitive symptoms of Alzheimer's.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option provided, it's challenging to address each incorrect choice directly. However, any option not identifying **acetylcholine** or its related pathway as the deficient component in Alzheimer's disease would be incorrect.
**Option B:** Similarly, without the option, we can't specify why it's wrong, but if it doesn't relate to the cholinergic system, it would not be correct.
**Option C:** and **Option D:** would be incorrect for the same reason, lacking a connection to the established neurochemical deficit in Alzheimer's.

**Clinical Pearl / High-Yield Fact**
A crucial point to remember is that the **cholinergic hypothesis** underlies the rationale for using cholinesterase inhibitors (e.g., donepezil) in the management of Alzheimer's disease, aiming to increase acetylcholine levels in the brain by preventing its breakdown.

**Correct Answer:** D. Acetylcholine